Article · 29 Aug 2026
Conference abstract
Lipopolysaccharide of Coxiella burnetii: A promising candidate molecule in search for a new Q fever vaccine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
C oxiella burnetii is etiological agent of Q fever. The disease is a worldwide zoonosis affecting mammals, birds and anthropods. In most cases, the human infection follows inhalation of aerosols derived from the excretions and secretions of infected animals such as cattle, sheep and goats. The recent large Q fever outbreak in the Netherlands stressed a need for a new and effective vaccine against Q fever.There were several attempts to produce safe and effective vaccines against the disease in the past. Although these vaccines showed high efficacy in establishing protection against infection, the application of them has been problematic. Vaccination often causes adverse local, or occasionally, systemic reactions in people previously sensitized to the pathogen. Therefore, skin tests, serological tests, and/or in vitro lymphocyte proliferation assays were pre-requisites prior to vaccination. This makes vaccination time-consuming and costly for large-scale applications. Lipopolysaccharide (LPS) has been considered to be a major antigen determinant of virulence expression and infection of C. burnetii. The LPS is highly immunogenic and contains a noticeable amount of two sugars virenose (Vir) and dihydrohydroxystreptose (Strep), which have not been found in other LPSs and are considered as unique biomarkers of the bacterium. We have shown that both sugars are located in the O-polysaccharide chain of LPS, mostly in terminal positions. Our studies on modification/modelling of the O-specific chain of C. burnetii have indicated that Vir and Strep could be indispensable components for the resulting protective qualities of the vaccine. It appears that LPS of C. burnetii is a promising candidate molecule for the development of a new subunit vaccine against Q fever.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Rudolf Toman”
- BylineArticles whose byline prints “Martina Frimmelova”